CRTC1 and Parkinson disease: Analysis of postmortem PD patients showed less PAK4 activity in apoptotic DA neurons, and activated PAK4 protected from neurotoxicity via phosphorylation of the CREB co-activator CRTC1 in rat models of PD (Won et al., 2016).